Birzeit Pharmaceuticals Company (PEX:BPC)
3.850
0.00 (0.00%)
At close: Apr 16, 2026
Birzeit Pharmaceuticals Company Company Description
Birzeit Pharmaceuticals Company operates as a pharmaceutical manufacturing company in the Palestinian Authority.
The company offers OTC products for alimentary system cardiovascular system, central nervous system, musculo-skeletal system, endocrine, genito-urinary system, diabetes, obstetrics and gynecology infections, affecting nutrition and metabolism, respiratory system, ophthalmic drugs, dermatological preparations, and dietary supplements, as well as ear, nose, and oropharynx therapeutic areas.
It serves the Ministry of Health, healthcare organizations and programs, and consumers through pharmacies and doctors.
The company was founded in 1973 and is headquartered in Ramallah, the Palestinian Authority.
Birzeit Pharmaceuticals Company
| Country | Palestinian Authority |
| Founded | 1973 |
| Industry | Pharmaceutical Preparations |
| Employees | 300 |
| CEO | Firas Kathem Nasereddin |
Contact Details
Address: Betunia Industrial Area Ramallah Palestinian Authority | |
| Phone | 970 2 2987573 |
| Website | bpc.ps |
Stock Details
| Ticker Symbol | BPC |
| Exchange | Palestine Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Firas Kathem Nasereddin | Chief Executive Officer |
| Abdul Qadir Younus Badwi | Chief Financial Officer |